On Patents

There is little evidence for all the concern over gene patents hurting basic biomedical research, writes Timothy Caulfield at Science Progress. Caulfield, who studies health law and policy at the University of Alberta, says the justification makes logical sense and has some anecdotal evidence, but there is a lack of hard data. Furthermore, he says this debate overshadows the effect that "commercialization pressure" has on academic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.